Acute hyperglycemia and activation of the β-adrenergic system exhibit synergistic inhibitory actions on growth hormone (GH) releasing hormone-induced GH release

European Journal of Endocrinology

Volumn 148, Issue 6, 2003, Pages 635-640

  Park, Cheolyoung ^a   Yang, Inmyung ^a   Woo, Jeongtaek ^a   Kim, Sungwoon ^a   Kim, Jinwoo ^a   Kim, Youngseol ^a   Park, Seungjoon ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; ISOPRENALINE; PROPRANOLOL; SOMATOSTATIN;

ADENOHYPOPHYSIS; ADRENERGIC ACTIVITY; ADRENERGIC NERVE CELL; ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD SAMPLING; CHOLINERGIC SYSTEM; CONCENTRATION RESPONSE; CONTINUOUS INFUSION; CONTROLLED STUDY; GROWTH HORMONE RELEASE; HORMONE INHIBITION; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; HYPOTHALAMUS; MALE; MEDICAL ASSESSMENT; NERVE CELL STIMULATION; NORMAL HUMAN; PRIORITY JOURNAL; SOMATOSTATIN RELEASE; STIMULUS RESPONSE; TIME;

ACUTE DISEASE; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; DRUG SYNERGISM; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; HYPERGLYCEMIA; HYPOTHALAMUS; ISOPROTERENOL; MALE; PITUITARY GLAND, ANTERIOR; PROPRANOLOL;

EID: 0037530659     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1480635     Document Type: Article

References (34)

1. Yalow RS, Goldsmith SJ & Berson SA. Influence of physiologic fluctuations in plasma growth hormone on glucose tolerance. Diabetes 1969 18 402-408.
2. Shibasaki T, Masuda A, Hotta M, Yamauchi N, Hizuka N, Takano K et al. Effects of ingestion of glucose on GH and TSH secretion: evidence for stimulation of somatostatin release from the hypothalamus by acute hyperglycemia in normal man and its impairment in acromegalic patients. Life Science 1989 44 431-438.
3. Sharp PS, Foley K, Chahal P & Kohner EM. The effect of plasma glucose on the growth hormone response to human pancreatic growth hormone releasing factor in normal subjects. Clinical Endocrinology 1984 20 497-501.
4. Davies RR, Turner S & Johnston DG. Oral glucose inhibits growth hormone secretion induced by human pancreatic growth hormone releasing factor 1-44 in normal man. Clinical Endocrinology 1984 21 477-481.
5. Masuda A, Shibasaki T, Nakahara M, Imaki T, Kiyosawa Y, Jibiki K et al. The effect of glucose on growth hormone (GH)-releasing hormone-mediated GH secretion in man. Journal of Clinical Endocrinology and Metabolism 1985 60 523-526.
6. Penalva A, Burguera B, Casabiell X, Tresguerres JA, Dieguez C & Casanueva FF. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin? Neuroendocrinology 1989 49 551-554.
7. Ghigo E, Mazza E, Imperiale E, Rizzi G, Benso L, Muller EE et al. Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature. Journal of Clinical Endocrinology and Metabolism 1987 65 452-456.
8. Ross RJ, Tsagarakis S, Grossman A, Nhagafoong L, Touzel RJ, Rees LH et al. GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH. Clinical Endocrinology 1987 27 727-733.
9. Freeman E, Trouzel R, Grossman A, Besser M & Ross R. Pyridostigmine, an acetylcholinesterase inhibitor, stimulates growth hormone release, but has no effect on basal thyrotropin-releasing hormone. Journal of Neuroendocrinology 1990 2 429-432.
10. Ghigo E, Bellone J, Mazza E, Imperiale E, Procopio M, Valente F et al. Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine. Clinical Endocrinology 1990 32 763-767.
11. Kelijman M & Frohman LA. The role of the cholinergic pathway in growth hormone feedback. Journal of Clinical Endocrinology and Metabolism 1991 72 1081-1087.
12. Yang I, Woo J, Kim S, Kim J, Kim Y & Choi Y. Combined pyridostigmine-thyrotrophin-releasing hormone test for the evaluation of hypothalamic somatostatinergic activity in healthy normal men. European Journal of Endocrinology 1995 133 457-462.
13. Reichlin S & Mothon S. Carbamazepine and phenytoin inhibit somatostatin release from dispersed cerebral cells in culture. Annals of Neurology 1991 29 413-417.
14. Kakucska I & Makara GB. Various putative neurotransmitters affect growth hormone (GH) release in rats with anterolateral hypothalamic deafferentation of the medial basal hypothalamus: evidence for mediation by a GH-releasing factor. Endocrinology 1983 113 318-323.
15. Perkins SN, Evans WS, Thorner MO & Cronin MJ. Beta-adrenergic stimulation of growth hormone release from perifused rat anterior pituitary cells. Neuroendocrinology 1983 37 473-475.
16. Krieg RJ, Perkins SN, Johnson JH, Rogers JP, Arimura A & Cronin MJ. Beta-adrenergic stimulation of growth hormone (GH) release in vivo, and subsequent inhibition of GH-releasing factor-induced GH secretion. Endocrinology 1988 122 531-537.
17. Krieg RJ Jr, Johnson JH & Adler RA. Growth hormone (GH) secretion in the pituitary-grafted male rat: in vivo effects of GH-releasing hormone and isoproterenol and in vitro release by individual somatotropes. Endocrinology 1989 125 2273-2278.
18. Blackard WG & Heidingsfelder SA. Adrenergic receptor control mechanism for growth hormone secretion. Journal of Clinical Investigation 1968 47 1407-1414.
19. Hansen AP. The effect of adrenergic receptor blockade on the exercise-induced serum growth hormone rise in normals and juvenile diabetics. Journal of Clinical Endocrinology and Metabolism 1971 33 807-812.
20. Mitchell ML, Suvunrungsi P & Sawin CT. Effect of propranolol on the response of serum growth hormone to glucagon. Journal of Clinical Endocrinology and Metabolism 1971 32 470-475.
21. 2 -induced growth hormone release in normal short and normal children. Journal of Clinical Endocrinology and Metabolism 1985 61 229-233.
22. Kelijman M & Frohman LA. Beta-adrenergic modulation of growth hormone (GH) autofeedback on sleep-associated and pharmacologically induced GH secretion. Journal of Clinical Endocrinology and Metabolism 1989 69 1187-1194.
23. Collu R, Leboeuf G, Letarte J & Ducharme JR. Stimulation of growth hormone secretion by levodopa-propranolol in children and adolescents. Pediatrics 1975 56 262-266.
24. Collu R, Brun G, Milsant P, Leboeuf G, Letarte J & Ducharme JR. Reevaluation of levodopa-propranolol as a test of growth hormone reserve in children. Pediatrics 1978 61 242-244.
25. Micic D, Popovic V, Kendereski A, Peino R, Dieguez C & Casanueva FF. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man. Clinical Endocrinology 1996 45 543-551.
26. Vance ML, Borges JL, Kaiser DL, Evans WS, Furlanetto R, Thominet JL et al. Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man. Journal of Clinical Endocrinology and Metabolism 1984 58 838-844.
27. Chiodini PG, Liuzzi A, Dallabonzana D, Oppizzi G & Verde GG. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine. Journal of Clinical Endocrinology and Metabolism 1985 60 48-52.
28. Davies RR, Turner S & Johnston DG. Oral glucose inhibits growth hormone secretion induced by human pancreatic growth hormone releasing factor 1-44 in normal man. Clinical Endocrinology 1984 21 477-481.
29. Casanueva FF, Villanueva L, Dieguez C, Diaz Y, Cabranes JA, Szoke B et al. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. Journal of Clinical Endocrinology and Metabolism 1987 65 634-642.
30. Richardson SB, Hollander CS, D'Eletto R, Greenleaf PW & Thaw C. Acetylcholine inhibits the release of somatostatin from rat hypothalamus in vitro. Endocrinology 1980 107 122-129.
31. Locatelli V, Torsello A, Redaelli M, Ghigo E, Massare F & Muller EE. Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin. Journal of Endocrinology 1986 111 271-278.
32. Torsello A, Panzeri G, Cermenati P, Caroleo MC, Ghigo E, Camanni F et al. Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat. Journal of Endocrinology 1988 117 273-281.
33. Wehrenberg WB, Wiviott SD, Voltz DM & Giustina A. Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement. Endocrinology 1992 130 1445-1450.
34. Richardson SB & Twente S. Inhibition of hypothalamic somatostatin release by beta-adrenergic antagonists. Endocrinology 1990 126 1043-1046.